Aiforia collaborates with PathAI to broaden access to AI-driven diagnostics
recent articles
Artera: Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal...
Proscia: Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges PHILADELPHIA — June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI)...
Paige and Breast International Group (BIG): The global partnership will leverage Paige’s technology to reduce unnecessary treatment, support better patient stratification, and help standardize the measurement of residual cancer...
Join Aiforia for their webinar on AI in lung cancer pathology PD-L1 on the edge: cut-offs, cognitive bias & the case for AI in lung cancer pathology Date: Monday, June 23, 2025 Time: 3:00 p.m. CEST / 9:00 a.m. EDT Register to join live...
From the Proscia blog: At this year’s Digital Pathology & AI Congress, I had the privilege of leading a pre-conference workshop with what might have seemed like an ambitious goal: help participants build a real AI application in under...
From the blog of Indica Labs: In this interview with Donald Allen of the Life Sciences Product Management team, Indica Labs proves its continuous innovation with the inclusion of a cutting-edge foundation model in HALO...
